Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simpinicline in diabetic gastroparesis
NCT02187094Phase 2Completed
- Sponsor
- Targacept
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simpinicline in gastroparesis, sponsored by Targacept. Started Jun 2014; status: completed.
02
Drugs
simpinicline
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT02187094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187094.